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1748-6815/ª 2015 Published by ElsevierSummary Velocardiofacial syndrome (VCFS) is associated with velopharyngeal insufficiency,
which occurs in approximately 75% of VCFS patients. Surgical management of velopharyngeal
insufficiency in VCFS patients is difficult with a high revision rate due to the anatomic and
physiological abnormalities of the velopharynx. The aims of this study were to evaluate the
thickness and symmetry of the levator veli palatini (LVP) muscle using magnetic resonance im-
aging (MRI), and to compare the findings in VCFS patients to those in patients with nonsyndro-
mic submucous cleft palate.
We conducted a prospective analysis of 17 VCFS patients (nine boys, eight girls; age range, 4
e9 years) and nine patients with submucous cleft palate without VCFS (eight boys, one girl;
age range, 4e13 years) who had undergone MRI between March 2009 and August 2013. The
thickness of the LVP muscle was measured at six locations in both groups. The symmetry
was determined by comparing the values between the average of the left three points and
the right three points.
The mean LVP muscle thickness was significantly thinner in VCFS patients (2.14  0.73 mm)
than in patients without VCFS (3.70  1.08 mm) (p < 0.001). In addition, the difference be-
tween the left and right sides of muscle thickness in the VCFS group was larger than that in
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Evaluation of the levator veli palatini muscle 1101The thinness and asymmetry of the LVP muscle should be considered when determining the
surgical management of velopharyngeal insufficiency in VCFS patients.
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Aesthetic Surgeons.Introduction
Velocardiofacial syndrome (VCFS) is the most common
syndrome associated with either cleft or noncleft problems
in velopharyngeal function.1,2 Of the patients with cleft
palates, 8.1% had VCFS.3 In addition, the prevalence of
VCFS is estimated to range from one in 2000 to one in 7000
people.1,4 VCFS is caused by a microdeletion of band q11.2
on chromosome 22.1 This is a complex disorder with a wide
variation in phenotypic expression.5 Essentially, every
organ, bodily function, and behavior can be affected, and
190 distinctive anomalies or patterns of anomalies, such as
congenital heart disease, palatal anomalies, speech and
language impairment, developmental delay, learning dis-
abilities, and psychiatric disorders, have been described.5
VCFS is usually diagnosed because of congenital heart
disease.5 Many patients without heart anomalies were
diagnosed with VCFS in early childhood because of hyper-
nasality and other speech impairments.5 One of the most
prominent symptoms of VCFS is hypernasal speech, which
occurs in approximately 75% of VCFS patients.1 Velophar-
yngeal insufficiency (VPI) is the inability to completely
close the velopharyngeal port during the production of oral
sounds. The common features of palatal anomalies in VCFS
patients are submucous cleft palate (SMCP) and occult
SMCP rather than overt cleft palate, and other anomalies of
the velopharynx also affect the velopharyngeal function in
VCFS.5
The goal of VPI treatment is to restore the functional
valve mechanism between the nasal cavity and the oral
cavity so that normal speech resonance can occur. Although
various approaches have been proposed for correcting VPI
in VCFS patients, the surgical management of VCFS is
inherently more difficult, and it results in significantly
poorer speech outcomes and a higher revision rate than the
surgical management of nonsyndromic cleft patients due to
abnormalities of the velopharynx.6e9 The closure mecha-
nism of the velopharyngeal port is influenced by move-
ments of the velum, the lateral pharyngeal walls, and the
posterior pharyngeal walls, which are aberrant anatomi-
cally and physiologically in VCFS.4 Therefore, surgeons
should consider these differences and characteristic find-
ings of the velopharynx to obtain favorable outcomes.
Various abnormalities of the velopharynx in VCFS have
been reported.10 However, no study has analyzed structural
abnormality of the levator veli palatini (LVP) muscle, which
is the primary muscle responsible for velar elevation during
speech. Magnetic resonance imaging (MRI) is an accurate,
noninvasive method for assessing the velopharyngeal
anatomy, which does not expose patients to ionizing radi-
ation.11,12 Additional advantages include the acquisition of
soft tissue images with a high resolution and the freeselection of a scanning plane.13 The aims of this study were
to evaluate the thickness and symmetry of the LVP muscle
using MRI in VCFS patients, and to compare the findings in
VCFS patients to those in patients with nonsyndromic SMCP.
Patients and methods
After receiving approval from the institutional review board
of the committee on clinical investigation (No. B-1005/
100-007), we conducted a prospective study, which
included 17 patients with VCFS and nine patients with
nonsyndromic SMCP who had visited the Department of
Plastic and Reconstructive Surgery of Seoul National Uni-
versity at Bundang Hospital between March 2009 and August
2013. None of the patients had a history of surgical pro-
cedures in the velopharyngeal region. A 22q11.2 deletion
was confirmed by using fluorescence in situ hybridization in
all VCFS patients. The VCFS group comprised five patients
with SMCPs and 12 patients with occult SMCPs.
With the parents’ consent, all patients underwent MRI
on the day before surgical management. Sagittal, axial,
coronal, and oblique coronal images of the velopharynx
were obtained using a Philips Achieva 3.0 T scanner (Philips
Healthcare, Best, The Netherlands). To prevent motion
artifacts, the patients were sedated with chloral hydrate
(50e75 mg/kg, orally) prior to MRI. Each patient was placed
in the standard supine position with his or her head
perpendicular to the table, and they were all continuously
monitored via pulse oximetry and were observed for
approximately 1 h after study completion to ensure com-
plete recovery. The oblique coronal plane passed through
the LVP muscle from its origin at the skull base to the
insertion of the LVP muscle at the velum. In reference to
sagittal scout images, the oblique coronal images were
obtained by scanning the planes parallel to the estimated
course of the LVP muscle in a superoposterior direction
from the velum (Figure 1). The scanning parameters of the
oblique coronal images were as follows: T2-weighted;
turbo-spin echo; repetition time, 4000 ms; effective echo
time, 80 ms; matrix, 284  280; field of view, 170e200 mm;
number of excitation, two; slice thickness, 1.5 mm; and
intersection gap, 0.
The image showing the thickest LVP muscle in the velum
was selected among the oblique coronal images. The
thickness of the LVP muscle was measured on the lateral
one-fourth point, midpoint, and medial one-fourth point
(total of three points) on each side. The symmetry was
determined by comparing the values between the average
of the left three points and the right three points. To
reduce variability, all measurements were performed by
the same person (S.H.A). The reliability of the measure-
ments was estimated by randomly selecting 10 patients
Figure 1 Magnetic resonance imaging scan in the oblique coronal plane. The arrows indicate the levator veli palatini muscles.
The inset in the upper left is a sagittal section showing the location of the oblique coronal plane.
Figure 2 Comparison of the thickness between the veloc-
ardiofacial syndrome (VCFS) patients and the nonsyndromic
submucous cleft palate (SMCP) patients. The mean levator veli
palatini muscle thickness is statistically significantly thicker in
the nonsyndromic SMCP patients than in the VCFS patients
()p < 0.001, t-test).
1102 M. Park et al.(five VCFS and five nonsyndromic SMCP patients) and
repeating all the measurements. The correlation coeffi-
cient between the first and second measurements was
0.918 (p < 0.01). The six measured values for each patient
were compared between the groups using Statistical Pack-
age for Social Science (SPSS), version 21.0 (SPSS, Inc.,
Chicago, IL, USA). A p-value of <0.05 was considered to be
statistically significant.
Results
Of the 17 patients with VCFS, nine were boys and eight were
girls. Their ages ranged from 4 to 9 years (average, 6.1 1.5
years). Of the nine patients with nonsyndromic SMCP, eight
were boys and one was a girl. Their ages ranged from 4 to 13
years (average, 6.3  2.8 years). The difference between
the ages of the groups was not significant (p Z 0.73). The
MRI scans were performed successfully without any arti-
facts in all patients. There were no cases of a decrease in
oxygen saturation under 95% during the sedation.
The mean thickness of the LVP muscles in each VCFS pa-
tient ranged from 0.88 to 3.32 mm (average,
2.14  0.73 mm). The mean LVP thickness in each non-
syndromic SMCP patient ranged from 2.25 to 5.60 mm
(average, 3.70 1.08mm). Nonsyndromic SMCP patients had
a significantly thicker LVP compared to that in VCFS patients
(p < 0.001, t-test) (Figure 2). The means and standard de-
viations of each point of measurement in the VCFS patients
compared to those in the nonsyndromic SMCP patients are
shown in Table 1. For each point, the nonsyndromic SMCP
patients had significantly thicker LVPs compared to those in
the VCFS patients (p < 0.05, t-test) (Figure 3).
For the mean thickness of each side in the VCFS group,
the right side was thicker in six patients and the left side was
thicker in 11. In the nonsyndromic SMCP group, the LVP
muscle was thicker on the right side in six patients and on theleft in two patients, and it was the same in one patient. The
difference between the average of the left and right sides of
muscle thickness was much larger in the VCFS group than in
the nonsyndromic SMCP group (0.25 mm vs. 0.09 mm).
Discussion
This study assessed the LVP muscle thickness in VCFS pa-
tients using MRI. Our findings suggested that VCFS patients
Table 1 The means and standard deviations of the levator
veli palatini muscle thickness at each measurement site.
Site Velocardiofacial
syndrome (n Z 17)
(mm)
Nonsyndromic
submucous
cleft palate
(n Z 9) (mm)
p-value
Right Lateral 1.90  0.61 3.62  1.04 a0.001
Middle 1.99  0.94 3.71  1.26 a0.001
Medial 2.15  0.91 3.91  1.44 a0.001
Left Medial 2.41  0.84 3.99  0.79 a<0.001
Middle 2.27  0.98 3.31  1.28 a0.028
Lateral 2.12  0.88 3.68  1.41 a0.002
a Statistically significant value.
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nonsyndromic SMCP patients. Ettema et al. reported that in
10 normal healthy adults, the average thickness of the
lateral portion of the LVP sling was 3.9 mm in women (mean
age, 27.8 years) and 4.6 mm in men (mean age, 26.6
years).13 Compared with these data, the LVP thickness of
VCFS children is approximately half of that in normal
adults. Moreover, our findings showed an asymmetric
thickness between the right and left sides of the LVP muscle
where the left side was significantly thicker in VCFS pa-
tients. Chegar et al. reported that 67% of their patients
with VCFS had asymmetric elevation of the velum during
speech, and 66% of them had left-sided hypoplasia.14 The
high rates of vascular abnormalities were found in patients
with VCFS.1,14e18 It has been hypothesized that vascular
anomalies may result in developmental sequences related
to unequal, interrupted, or diminished perfusion.15,16
Moreover, neurologic component might explain the leva-
tor muscle hypoplasia and asymmetry.14,19
There are a number of studies on the effects of trans-
palatal transmission in connection with resonance. McWil-
liams reported that some patients had thin palates and noFigure 3 Comparison of the mean levator veli palatini muscle th
syndrome (VCFS) patients and the nonsyndromic submucous cleft
ferences between the two groups at all points ()p < 0.01, yp < 0.evidence of submucous clefts20; however, the patients
closed the velopharyngeal valve during speech, and they
often had mild hypernasality. Hoit et al. investigated
velopharyngeal function among four age groups (20e30,
40e50, 60e70, and 80þ years). They reported that a
greater acoustic transfer was expected if the bony palate,
the muscular palate, or both were less dense. Thus, they
presumed that certain age-related structural modifications
can increase the sympathetic transfer of acoustic energy
from the oral cavity to the nasal pathways.21 In addition,
Gildersleeve-Neumann et al. reported that some patients
with a repaired cleft palate may achieve complete velo-
pharyngeal closure and still have resonance problems due
to the acoustic transmission characteristics of their soft
palate.22 In 2006, Bundy reported that the transpalatal
transfer of acoustic energy accounts for approximately 80%
of nasalance during the production of voiced stop conso-
nants by noncleft speakers, and a repaired cleft palate may
induce the difference in levels of transpalatal nasalance
due to inherent tissue deficits and/or the effects of surgical
scarring.23
Hypernasality is a separate entity from VPI, because the
acoustic symptom does not necessarily correlate with the
physical size of the velopharyngeal gap.5 Even minimal
velopharyngeal gaps often result in severe hypernasality.
Approximately 75% of subjects with VCFS have hypernasal
speech, and their hypernasality is usually severe.5 It is
presumed that the thin LVP muscle plays a role in severe
hypernasality. The length and position of LVP muscle were
found to be asymmetric in many VCFS patients. Along with
the structural problem, the asymmetric elevation of the LVP
muscle during speech was also found, which might result in
an asymmetric VPI.5,14 Besides the reduced velar muscula-
ture and the asymmetric LVP muscle, other anatomical and
physiologic abnormalities (e.g., an excessively deep phar-
ynx with a large volume, pharyngeal hypotonia, abnormal
pharyngeal musculature, and a hypoplastic or aplastic
adenoid) can affect the velopharyngeal function of subjects
with VCFS, making the treatment of velopharyngealickness at six measurement sites between the velocardiofacial
palate (SMCP) patients. There are statistically significant dif-
05, t-test).
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in this region may cause airway and swallowing problems,
which are frequently found.14
The surgical options include Furlow palatoplasty,
sphincter pharyngoplasty, and pharyngeal flap surgery.
Furlow palatoplasty improves the velopharyngeal function
by lengthening the velum while reorienting the velar mus-
cles into a more normal transverse position.25 Antonio et al.
used Furlow Z-plasty for treating VPI; they divided patients
into three groups: nonsyndromic, VCFS, and syndromic.9
Furlow Z-plasty produced excellent results in the non-
syndromic group, varied results in the syndromic group, and
poor results in the VCFS group. The majority of patients in
the three groups showed similar patterns of velopharyngeal
function evidenced by perceptual, aerodynamic, endo-
scopic, and cephalometric studies preoperatively; there-
fore, VCFS patients may be poor candidates for double-
opposing Z-plasty. These findings support the hypothesis
that there may be quantitative and qualitative differences
in the mechanisms of speech production in children with
VCFS.
Sphincter pharyngoplasty decreases the circumference
of the velopharyngeal port to aid in the velopharyngeal
closure mechanism. This surgical method is often used in
patients with large-gap coronal, circular velopharyngeal
closure, bow-tie closure, or hypodynamic velopharyngeal
movement.26,27 Losken et al. investigated the results of
sphincter pharyngoplasty in VCFS patients, and they
compared the results to non-VCFS patients.6 They demon-
strated that sphincter pharyngoplasty was safe and effec-
tive for correcting VPI in VCFS patients. However, the
revision rate in VCFS patients was significantly higher than
that in patients without VCFS. An imaging and histologic
study demonstrated that the superior pharyngeal
constrictor muscle in VCFS patients (age range, 3e29 years)
was significantly thinner compared to that in patients
without VCFS (age range, 3e27 years).28 The abnormal su-
perior pharyngeal constrictor muscle may reduce the
effectiveness of sphincter pharyngoplasty, and it may also
contribute to an inconsistent level of improvement post
operatively.
The pharyngeal flap, commonly superiorly based, is a
functional valve between the nasal cavity and the oral
cavity that restores velopharyngeal competence. Tatum
et al. performed pharyngeal flap surgery on 20 patients
with VCFS, including five patients who had previously un-
dergone other surgical procedures for VPI, and hypernasal
resonance and abnormal nasal air escape during speech
were successfully eliminated in 18 of 20 patients.29 Ac-
cording to Chegar et al., pharyngeal flap surgery was
considered to be the most effective treatment in VCFS
patients with VPI, with successful elimination of hyper-
nasal resonance in almost all the cases.30 Ysunza et al.
performed the surgery on 29 VCFS patients who showed
residual VPI after palatal closure.31 Nine patients under-
went sphincter pharyngoplasty, and 66% improved to
moderate hypernasality. However, 20 patients underwent
the pharyngeal flap, and 85% improved to normal nasal
resonance with mild hypernasality. There is no significant
difference in the preoperative mean size of the gap be-
tween the two groups. However, surgeons should be care-
ful to avoid sleep apnea when performing the pharyngealflap in VCFS patients who have an asymmetric airway with
hypertrophic tonsils.14
There are issues to consider when deciding to perform a
surgery. A small airway, hypotonicity of the velum and
pharyngeal muscles, and medially displaced internal ca-
rotid arteries are factors that make surgery more compli-
cated.2,29,32 To obtain favorable results, a surgical
approach to VPI in VCFS patients should be carefully
designed, and it should consider and precisely assess any
anatomical and physiological abnormalities. In the present
study, the thickness of the LVP muscle in VCFS patients was
significantly decreased compared to that in nonsyndromic
SMCP patients. In addition, asymmetry of the LVP muscles
was present in VCFS patients. Thus, anatomical abnormal-
ities of the LVP muscles can have a negative effect on
velopharyngeal function. In conclusion, the structural de-
fects of the LVP muscles in VCFS patients should be the
contributing factor to suboptimal results after surgical
procedures that depend on the function of the LVP muscle.
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